Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 S 31st St
Temple, TX 76508Phone+1 254-724-2111
Education & Training
- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Pathology-Anatomic and Clinical, 1992 - 1996
- Mysore Medical CollegeClass of 1982
Certifications & Licensure
- TX State Medical License 1996 - 2026
- IA State Medical License 1994 - 2012
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Molecular Genetic Pathology
Clinical Trials
- A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel Start of enrollment: 2015 Jan 01
- A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients Start of enrollment: 2015 Dec 01
Publications & Presentations
PubMed
- 40 citationsCalcitonin Gene-Related Peptide Protects Against Hypertension-Induced Heart and Kidney DamageScott C. Supowit, Arundhati Rao, Mark C. Bowers, Huawei Zhao, Gregory D. Fink
Hypertension. 2005-01-01 - 103 citationsMorphological and functional heterogeneity of the mouse intrahepatic biliary epitheliumShannon Glaser, Eugenio Gaudio, Arundhati Rao, Lisa M. Pierce, Paolo Onori
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2009-04-01 - 38 citationsDiagnosis and antibiotic treatment of group a streptococcal pharyngitis in children in a primary care setting: impact of point-of-care polymerase chain reaction.Arundhati Rao, Bradley Berg, Theresa Quezada, Robert Fader, Kimberly Walker
BMC Pediatrics. 2019-01-16
Journal Articles
- Multicenter Clinical Evaluation of the Luminex Aries Flu A/B & RSV Assay for Pediatric and Adult Respiratory Tract SpecimensArundhati Rao, MD, mBio
Press Mentions
- Biomarker Predicts Poor Prognosis in African-Americans with Triple-Negative Breast Cancer, Study FindsFebruary 20th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: